drugset / Press release
The Scientific and Clinical Potential of 89Zr Crefmirlimab Berdoxam (CD8 ImmunoPET™) to Visualize and Quantify Tumor-Infiltrating CD8+ T Cells
2023-09-06 · ImaginAb, Inc. · original imaginab.com ↗
back The Scientific and Clinical Potential of 89Zr Crefmirlimab Berdoxam (CD8 ImmunoPET™) to Visualize and Quantify Tumor-Infiltrating CD8+ T Cells The Scientific and Clinical Potential of 89Zr Crefmirlimab Berdoxam (CD8 ImmunoPET™) to Visualize and Quantify Tumor-Infiltrating CD8+ T Cells presented at WMIC 2023
The release as fetched from its publisher. imaginab.com ↗